BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 28, 2008
View Archived Issues
Nissan Chemical patents novel antithrombocytopenic compounds
Read More
New therapeutic agents for thrombotic disorders described in recent patent literature
Read More
Novartis reports 2007 results
Read More
Regulatory T-cell loss of function triggers type 1 diabetes in mice
Read More
Epix achieves milestone in collaboration with Cystic Fibrosis Foundation
Read More
FDA Advisory Committee votes favorably for Entereg in postoperative ileus
Read More
New treatment options for inflammatory and allergic conditions disclosed in Icos patent
Read More
Nabi Biopharmaceuticals initiates new strategic alternatives process
Read More
Patient enrollment begins for NIH funded SFP clinical study
Read More
Bayer extends its liver cancer product portfolio in Japan
Read More
CombinatoRx provides update on 2008 goals
Read More
Combination of quetiapine and a mood stabilizer more effective in preventing mood episodes
Read More
Data Safety Monitoring Board reviews phase III defibrotide trial
Read More
First and only antiinflammatory pain relief patch available in the U.S.
Read More
GSK allies with institutions in tuberculosis and malaria drug discovery programs
Read More
GSK/MRC to identify new therapeutic targets from genetic association studies
Read More
M.D. Anderson and AstraZeneca form cancer-related neuropathic pain alliance
Read More
Protherics initiates OncoGel phase IIb study in esophageal cancer
Read More
BioCryst updates clinical development plan for intramuscular peramivir
Read More
Novartis reports positive primary endpoint from the FIRST-STEP study of Stalevo
Read More
Cangene's recombinant human growth hormone approved by the FDA
Read More
Kipres approved for additional indication of allergic rhinitis
Read More
Promising preclinical results for FGL in stress-induced cognitive deficits
Read More
Kirin Pharma launches Regpara tablets for secondary hyperparathyroidism
Read More
EMEA recommends approval of novel oral anticoagulant, Pradaxa
Read More
Clexane, sanofi-aventis' anticoagulant, is approved for marketing in Japan
Read More
Antibacterial Gracevit receives manufacturing and marketing approval in Japan
Read More
First launch of Optaflu in Germany
Read More